The FDA has published a draft version of proposed guidance for “Informed Consent” for all IRB’s and research uses of FDA regulated entities. Comment period expires September 15, 2014.
Learn More
FDA Publishes Draft Informed Consent Guidance
The FDA has published a draft version of proposed guidance for “Informed Consent” for all IRB’s and research uses of FDA regulated entities. Comment period expires September 15, 2014.
Learn More